Food and Drug Administration scientists are questioning whether study results are reliable enough to warrant approval for a new cancer drug from Johnson & Johnson.
FDA questions data for J&J ovarian cancer drugCourtesy Newsvine - business Mon, 07/13/2009 - 08:20
Food and Drug Administration scientists are questioning whether study results are reliable enough to warrant approval for a new cancer drug from Johnson & Johnson. Related itemsMead Johnson Says Its Tests Show Enfamil Baby Formula...
Medical Device Makers Shun U.S.
AP Enterprise: FDA helps states get execution drug
Hunt(R) Boston(R) 1800 Series Electric Sharpener,...
SLIM CLIP
|
Popular by tags WeekMonth |
Post new comment